Published in J Immunol on April 01, 1986
Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. J Clin Invest (1987) 2.74
Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun (1991) 1.67
Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit. Infect Immun (1993) 1.42
Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infect Immun (1994) 1.42
Recognition of the galactose- or N-acetylgalactosamine-binding lectin of Entamoeba histolytica by human immune sera. Infect Immun (1987) 1.32
Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites. Infect Immun (1989) 1.28
Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect Immun (1994) 1.25
Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii. J Clin Invest (1990) 1.19
Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen. Infect Immun (1995) 1.17
Identification of the galactose-adherence lectin epitopes of Entamoeba histolytica that stimulate tumor necrosis factor-alpha production by macrophages. Proc Natl Acad Sci U S A (1995) 1.10
Human T-lymphocyte proliferation, lymphokine production, and amebicidal activity elicited by the galactose-inhibitable adherence protein of Entamoeba histolytica. Infect Immun (1992) 1.07
The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide. Infect Immun (1997) 1.05
A review of amoebic liver abscess for clinicians in a nonendemic setting. Can J Gastroenterol (2012) 1.04
In vitro and in vivo studies of macrophage functions in amebiasis. Infect Immun (1988) 1.02
Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Immunology (1994) 1.02
Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA. Infect Immun (2007) 1.01
Inflammatory reaction in experimental hepatic amebiasis. An ultrastructural study. Am J Pathol (1988) 0.97
Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies. Curr Opin Immunol (2007) 0.96
Progress towards development of a vaccine for amebiasis. Clin Microbiol Rev (1997) 0.94
Entamoeba histolytica suppresses gamma interferon-induced macrophage class II major histocompatibility complex Ia molecule and I-A beta mRNA expression by a prostaglandin E2-dependent mechanism. Infect Immun (1995) 0.93
Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect Immun (1995) 0.91
Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera. Infect Immun (1990) 0.90
Entamoeba histolytica alters arachidonic acid metabolism in macrophages in vitro and in vivo. Immunology (1992) 0.88
Host-pathogen interaction in amebiasis and progress in vaccine development. Eur J Clin Microbiol Infect Dis (1998) 0.83
The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica. J Biomed Biotechnol (2010) 0.81
Murine T-cell clones against Entamoeba histolytica: in vivo and in vitro characterization. Immunology (1989) 0.81
Entamoeba histolytica proteins modulate the respiratory burst potential by murine macrophages. Immunology (1993) 0.79
T-cell suppression and selective in vivo activation of TH2 subpopulation by the Entamoeba histolytica 220-kilodalton lectin. Infect Immun (1995) 0.76
Effects of gamma interferon on syntheses of DNA and proteins by Entamoeba histolytica. Infect Immun (1989) 0.75
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med (1983) 14.08
An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med (1981) 7.35
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest (1983) 5.88
Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med (1984) 4.73
The macrophage as an effector cell. N Engl J Med (1980) 4.30
Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. J Immunol (1985) 3.85
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med (1984) 3.73
Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. J Exp Med (1979) 3.72
Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis (2000) 3.72
Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet (1998) 3.55
Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest (1981) 3.50
Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. J Immunol (1983) 3.49
Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. J Exp Med (1980) 3.43
Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest (1987) 3.16
Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. J Clin Invest (1983) 3.06
The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med (1975) 3.06
Cytopathogenic mechanisms of Entamoeba histolytica. J Exp Med (1980) 3.06
Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J Exp Med (1984) 3.02
Experimental modulation of occluding junctions in a cultured transporting epithelium. J Cell Biol (1980) 3.00
Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J Exp Med (1979) 2.93
Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. J Clin Invest (1987) 2.74
Serious infections from Bacillus sp. JAMA (1979) 2.67
Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med (1978) 2.54
Serious infections caused by Streptococcus milleri. Am J Med (1978) 2.47
Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. J Immunol (1987) 2.45
Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother (2002) 2.43
Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J Immunol (1982) 2.42
Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates. J Exp Med (1985) 2.37
Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer (1998) 2.36
Subunit structure of the galactose and N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. J Biol Chem (1989) 2.30
Interaction between Entamoeba histolytica and human polymorphonuclear neutrophils. J Infect Dis (1981) 2.26
Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med (1981) 2.22
Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin Infect Dis (2000) 2.21
Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. J Immunol (1982) 2.09
Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. J Exp Med (1985) 2.03
Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol (1985) 2.00
Lymphokine enhances oxygen-independent activity against intracellular pathogens. J Exp Med (1983) 1.93
Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis. J Infect Dis (1993) 1.88
Atypical pneumonias. Med Clin North Am (1980) 1.88
Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages. J Immunol (1986) 1.87
Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J Immunol (1988) 1.87
Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. N Engl J Med (1985) 1.87
Reliability of the Washington University Road Test. A performance-based assessment for drivers with dementia of the Alzheimer type. Arch Neurol (1997) 1.84
Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica. J Infect Dis (1990) 1.84
Cellular bases of experimental amebic liver abscess formation. Am J Pathol (1984) 1.83
Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann Intern Med (1997) 1.80
Malaria--the mime revisited: fifteen more years of experience at a New York City teaching hospital. Am J Med (1992) 1.77
Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm (1979) 1.72
Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect (2014) 1.71
Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J Exp Med (1981) 1.71
Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J Immunol (1989) 1.70
Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.69
Regulation of arachidonic acid metabolism by macrophage activation. J Exp Med (1982) 1.69
Contact-dependent cytopathogenic mechanisms of Trichomonas vaginalis. Infect Immun (1985) 1.68
N-Acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. I. Partial purification and relation to amoebic virulence in vitro. J Infect Dis (1985) 1.67
Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun (1991) 1.67
Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun (1994) 1.67
A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin Infect Dis (1999) 1.64
Norwegian scabies and a toxic shock syndrome toxin 1-producing strain of Staphylococcus aureus endocarditis in a patient with trisomy 21. Clin Infect Dis (1998) 1.60
Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J Travel Med (1999) 1.59
Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. J Exp Med (1997) 1.59
Trial of oral miltefosine for visceral leishmaniasis. Lancet (1998) 1.58
Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis. Ann Trop Med Parasitol (2002) 1.54
The dynamics of granuloma formation in experimental visceral leishmaniasis. J Exp Med (1988) 1.51
In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. J Immunol (1987) 1.51
Adherence of Entamoeba histolytica trophozoites to rat and human colonic mucosa. Infect Immun (1985) 1.50
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. BMJ (2001) 1.50
Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J Immunol (1985) 1.50
Invasive infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis (1990) 1.49
Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage. J Clin Invest (1985) 1.49
Splenic cytokine responses in Indian kala-azar before and after treatment. J Infect Dis (1998) 1.49
Entamoeba histolytica. Phagocytosis as a virulence factor. J Exp Med (1983) 1.48
Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999. Clin Infect Dis (2000) 1.47
Septic pulmonary embolism complicating a central venous catheter. Chest (1990) 1.47
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am J Med (1988) 1.45
Localization of permeability barriers in the frog skin epithelium. J Cell Biol (1971) 1.45
Macrophage oxygen-dependent antimicrobial activity. IV. Role of endogenous scavengers of oxygen intermediates. J Exp Med (1980) 1.44
Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose-inhibitable adherence protein antigen in sera and feces. J Clin Microbiol (1993) 1.44
Role and effect of TNF-alpha in experimental visceral leishmaniasis. J Immunol (1994) 1.43
Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg (1997) 1.43
[Infectious endocarditis of the native valve: its epidemiological profile and an analysis of its mortality between the years 1984 and 1993]. Med Clin (Barc) (1995) 1.41
Increase in type I and type III collagens in human alcoholic liver cirrhosis. Proc Natl Acad Sci U S A (1976) 1.41
Perceptual asymmetry, plasma cortisol, and response to treatment in depressed outpatients. Biol Psychiatry (1991) 1.40
[Study of the Eustachian valve using two-dimensional echocardiography]. Rev Esp Cardiol (1988) 1.39
The interaction of human neutrophils and Entamoeba histolytica increases cytopathogenicity for liver cell monolayers. J Infect Dis (1986) 1.36
A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J Infect Dis (1995) 1.35
Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates. J Exp Med (1981) 1.34
Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. Clin Infect Dis (2002) 1.33
Recognition of the galactose- or N-acetylgalactosamine-binding lectin of Entamoeba histolytica by human immune sera. Infect Immun (1987) 1.32
Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa. J Reticuloendothel Soc (1982) 1.32
Coping with AIDS. The special problems of New York City. N Engl J Med (1987) 1.31
Antimicrobial therapy in pulmonary aspiration. Am J Med (1979) 1.31
Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin Infect Dis (2000) 1.29
A review of the parasite cellular mechanisms involved in the pathogenesis of amebiasis. Rev Infect Dis (1983) 1.28